Document is current

Article History

Received: 31 January 2026

Accepted: 22 June 2026

First Online: 18 July 2026

Declarations

Ethics approval and consent to participate: The study received ethical approval from Ibrahim AlQureshi’s (IBRAQ) HR Oversight Committee with approval number (JD/ [2026] / 001). All research procedures were performed in accordance with the ethical guidelines and regulations of the Organisation and the principles outlined in the Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study. All participants were briefed on the nature of the research, the voluntary nature of their participation, and their right to withdraw at any stage without prejudice. Written informed consent was documented prior to data collection.

Competing interests: The authors declare no competing interests.

Consent for publication: Informed consent to participate and informed consent to publish the findings of this study were obtained from all individual participants included in the study.

Clinical trial number: Not applicable.